Building iteration into the product commercialization process can help life sciences companies avoid many of the missteps ...

Leadership in pharma means questioning assumptions, amplifying diverse voices, and creating environments where authenticity ...

Toxicity related to the systematic delivery of IL-12, a well-known and widely researched anti-tumor cytokine, has limited its ...

AI in life sciences raises various patent law considerations, including subject matter eligibility, novelty/obviousness, and sufficiency of disclosure, explains patent attorney Noah K. Tilton.

A looming patent cliff is driving Big Pharma reorganization. Executives making career moves must understand differences in ...

Optimize your clinical trials with Citeline’s Strategic Solutions. Drug development is a lengthy and costly endeavor, often taking 10–15 years and up to $2 billion to bring a therapy to market. To ...

As 2024 concludes, molecular medicine continues its steady 6-7% annual growth, while diversifying its therapeutic landscape. Notably, Q4 brought approvals across gene, cell, and RNA therapies: ...